These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8791956

  • 1. Methotrexate for the treatment of refractory Crohn's disease.
    Lémann M, Chamiot-Prieur C, Mesnard B, Halphen M, Messing B, Rambaud JC, Gendre JP, Colombel JF, Modigliani R.
    Aliment Pharmacol Ther; 1996 Jun; 10(3):309-14. PubMed ID: 8791956
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 3. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study.
    Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G.
    Dig Liver Dis; 2003 Sep 12; 35(9):619-27. PubMed ID: 14563183
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2003 Sep 12; (1):CD003459. PubMed ID: 12535475
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of parenteral methotrexate in refractory Crohn's disease.
    Chong RY, Hanauer SB, Cohen RD.
    Aliment Pharmacol Ther; 2001 Jan 12; 15(1):35-44. PubMed ID: 11136276
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF.
    Am J Gastroenterol; 2000 Jul 12; 95(7):1730-4. PubMed ID: 10925976
    [Abstract] [Full Text] [Related]

  • 9. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 10. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW.
    N Engl J Med; 2000 Jun 01; 342(22):1627-32. PubMed ID: 10833208
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Macdonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006884. PubMed ID: 19821390
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 07; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
    Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M.
    N Engl J Med; 1995 Feb 02; 332(5):292-7. PubMed ID: 7816064
    [Abstract] [Full Text] [Related]

  • 14. Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease.
    Gökbulut V, Özin Y, Kalkan İH, Arı D, Yüksel M, Kılıç ZMY, Kayaçetin E.
    Turk J Gastroenterol; 2022 Feb 02; 33(2):111-118. PubMed ID: 35115294
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
    Mesonero F, Castro-Poceiro J, Benítez JM, Camps B, Iborra M, López-García A, Torres P, Esteve M, Tosca J, Bertoletti F, Almela P, Calvet X, Vera I, Bujanda L, Gomollón F, Rodríguez C, Antolín B, Busquets D, Hernández A, Rivero M, Monfort I Miquel D, Castaño-García A, Gisbert JP, Domènech E, López-Sanromán A, ENEIDA Project of GETECCU.
    Aliment Pharmacol Ther; 2021 May 02; 53(9):1021-1029. PubMed ID: 33715177
    [Abstract] [Full Text] [Related]

  • 16. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
    Din S, Dahele A, Fennel J, Aitken S, Shand AG, Arnott ID, Satsangi J.
    Inflamm Bowel Dis; 2008 Jun 02; 14(6):756-62. PubMed ID: 18275071
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.
    J Pediatr Gastroenterol Nutr; 2009 May 02; 48(5):526-30. PubMed ID: 19412004
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of symptomatic remission in patients with Crohn's disease.
    Stark ME, Tremaine WJ.
    Mayo Clin Proc; 1993 Dec 02; 68(12):1183-90. PubMed ID: 7902474
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
    Oren R, Moshkowitz M, Odes S, Becker S, Keter D, Pomeranz I, Shirin H, Reisfeld I, Broide E, Lavy A, Fich A, Eliakim R, Patz J, Villa Y, Arber N, Gilat T.
    Am J Gastroenterol; 1997 Dec 02; 92(12):2203-9. PubMed ID: 9399753
    [Abstract] [Full Text] [Related]

  • 20. Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.
    Chauvin A, Le Thuaut A, Belhassan M, Le Baleur Y, Mesli F, Bastuji-Garin S, Delchier JC, Amiot A.
    Dig Liver Dis; 2014 Aug 02; 46(8):695-700. PubMed ID: 24893686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.